000950 重药控股
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(3,609,429)754,670(186,737)508,534285,829
投资活动产生之现金流量净额(25,831)163,748(182,464)(358,384)(191,239)
筹资活动产生之现金流量净额2,511,305(954,435)48,334252,4921,179,870
汇率变动对现金及现金等价物的影响----0----
现金及现金等价物净增加/(减少)(1,123,956)(36,016)(320,867)402,6421,274,459
期初现金及现金等价物余额4,750,9664,786,9835,107,8504,705,2073,430,748
期末现金及现金等价物余额3,627,0114,750,9664,786,9835,107,8504,705,207